Table 1 Case reports about primary omental synovial sarcoma
From: A rare case report of omental synovial sarcoma complicated hemoperitoneum and literature review
References | Age (years)/Sex | Chef complaints | Pathological result | Molecular test | Treatment | Outcome | |
|---|---|---|---|---|---|---|---|
1 | Ko et al. [11] | 37/female | Abdominal pain (10 cm mass) | Biphasic synovial sarcoma | N/A | Surgery: Removal of a tumor Chemotherapy | Time to progression: 6 months Survival time: at least 6 years |
2 | Hemmings et al. [12] | 37/female pregnant | Abdominal pain (15 cm mass) | N/A | The (X;18) translocation | Surgery: removal of a tumor Chemotherapy | Time to progression: 9 months Survival time: 3 years |
3 | Wang et al. [13] | 66/male | Abdominal distension, weight loss (20 cm mass) | Biphasic synovial sarcoma | N/A | Surgery: Removal of a tumor | Time to progression: 2 months Survival time: 2 months |
4 | Indranil et al. [14] | 16/female | Abdominal pain, vomiting (9.5 cm mass) | Monophasic synovial sarcoma | The (X;18) translocation | Surgery: Removal of a tumor Chemotherapy | Time to progression: 13 months Survival time: 13 months |
5 | Iwahashi et al. [5] | 51/female | Abdominal distension (12.5 cm mass) | Poorly differentiated synovial sarcoma | The fusion gene SYT-SSX was not found | Surgery: Removal of a tumor Chemotherapy Targeted therapy: Pazopanib | Time to progression: 7 months Survival time: N/A |
6 | Serrano et al. [15] | 53/female | Abdominal pain, weight loss (19 cm mass) | Monophasic synovial sarcoma | Gene SS18 (SYT) at 18q11 was rearranged on 93% of the tumor cells | Surgery: Removal of a tumor Chemotherapy | Time to progression: N/A (> 12 months) Survival time: N/A |
7 | Our case | 37/male | Abdominal pain, abdominal distension (18 cm) | Biphasic synovial sarcoma | N/A | Surgery: Removal of a tumor Chemotherapy | No progression until July 2024 (3 years from onset) |